Science, Computers & Technology Civil Procedure Health

Pharmaceutical Industry Healthcare Data Breach FDA Prescription Drugs False Claims Act (FCA) PHI Class Action Medical Devices Health Care Providers Patents HIPAA Popular HHS Personally Identifiable Information Data Protection Affordable Care Act Hospitals SCOTUS Section 340B Qui Tam Appeals Medicare Orphan Drugs Pharmaceutical Patents Biosimilars Whistleblowers Pharmacies BPCIA Fraud Generic Drugs Corporate Counsel Medicaid Patent Infringement Patent-Eligible Subject Matter Cyber Attacks Dismissals DOJ Cybersecurity Electronic Medical Records Patent Litigation Physicians Australia Class Certification Medical Records PHRMA Preliminary Injunctions Standing Summary Judgment CMS DNA Hackers HRSA Off-Label Promotion Settlement Amgen Anti-Kickback Statute Compliance FDCA Healthcare Fraud Identity Theft Negligence OCR Sandoz v Amgen Breach of Contract Clinical Trials Discovery Health Insurance Putative Class Actions Telemedicine ANDA Biotechnology Covered Entities Data Security Kickbacks Life Sciences Manufacturers Off-Label Use Patient Confidentiality Breaches Preemption Relators Sherman Act State Medical Board Telehealth Advertising Antitrust Litigation Canada CMIA First Amendment First-to-File FTC Hatch-Waxman HITECH Insurance Industry Omnicare Abbott Laboratories Article III Attorney-Client Privilege Corrective Actions Cyber Crimes Damages Data Privacy Defense Strategies Drug Pricing EHR FCRA FFDCA Interpretive Rule Jurisdiction Legal Ethics Mayo v. Prometheus Myriad OIG Patent Invalidity Patient Privacy Rights Pleading Standards Product of Nature Doctrine Sandoz Settlement Agreements Subpoenas USPTO Warning Labels ALJ AMP v Myriad Apotex Audits Clinical Laboratories CLS Bank v Alice Corp Comment Period Commercial General Liability Policies Commercial Marketing Confidential Information Controlled Substances Drug Compounding Enforcement Actions Expert Testimony Federal Rules of Civil Procedure Genetic Materials HIPAA Breach Injury-in-Fact Invasion of Privacy Labeling Legislative Agendas Litigation Strategies Medicare Part B Medicare Part D Mental Health Myriad-Mayo NIH Omnibus Guidance Patent Dance Pay-For-Delay Personalized Medicine Public Disclosure SEC Section 101 Software Stark Law State Action Immunity Statute of Limitations Stem cells Sutter Health TRICARE Unfair or Deceptive Trade Practices Vaccinations AbbVie Administrative Authority Administrative Procedure Act Amarin Amended Complaints Anthem Blue Cross Anti-Competitive Antitrust Provisions Antitrust Violations Biologics Blue Cross Blue Shield Business Associates Cephalon Certiorari CIGNA Civil Monetary Penalty Commerce Clause Confidentiality Agreements Criminal Prosecution Department of Health Diagnostic Method Dismissal With Prejudice Dispute Resolution Drug Safety Duty to Defend Duty to Warn Electronically Stored Information Employer Liability Issues En Banc Review Encryption Evidence Expert Witness Failure To Warn False Advertising False Statements Final Rules Financial Conduct Authority (FCA) Healthcare Reform HELP Human Genes In-Person Exam Insurance Litigation Inter Partes Review Proceedings IRS Johnson & Johnson LabMD Learned Intermediary Long-Term Care Marketing Medical Malpractice Medicare Access and CHIP Reauthorization (MACRA) Medicare Part A Medtronic Merck Motion for Reconsideration Motion to Dismiss NC Board of Dental Examiners v FTC Negligent Misrepresentation Notice Requirements Novartis OMB Omnicare v Laborers District Council Online Advertisements Overpayment Patent Applications Petition for Writ of Certiorari Pharmacist Prescription Drug Coverage Privacy Laws Privacy Policy Product Hopping Professional Liability Proposed Rules Proximate Cause Public Health Punitive Damages Reporting Requirements Retaliation Reversal Reverse Payment Settlement Agreements Rule 9(b) Rulemaking Process Safe Harbors SAIC Section 11 Section 5 Securities Act of 1933 Skilled Nursing Facility Software Developers Split of Authority Statement of Opinion Teva Pharmaceuticals Trade Secrets Travelers Unjust Enrichment Wrongful Death Zika Abuse of Discretion Acquisitions Actavis Inc. Actual Injuries Administrative Appeals Administrative Priority Administrative Proceedings Admissible Evidence Advanced Notice of Proposed Rulemaking (ANPRM) Adverse Employment Action Affirmative Defenses Akamai Technologies Alternative Medicine Alternative Payment Models (APM) American Bar Association (ABA) Amicus Briefs Analytics Anthem Insurance App Developers Arbitrary and Capricious Arbitration Ariosa Ascertainable Class AstraZeneca Attorney's Fees Balancing Test Bayer Bayh-Dole Act Behavioral Advertising Bilski Biologics Price Competition and Innovation Act of 2009 Birth Defects Black Box Warnings Board of Directors Bodily Injury Boston Scientific BRCA Breach Notification Rule Breach of Duty Breach of Implied Contract Bribery Bristol-Myers Squibb Bulk Purchasing Burden of Proof CAFA Calculation of Damages Cancer CareFirst Case Consolidation CBR Systems Chemicals Chief Compliance Officers CHIP Chiropractors Choice-of-Law Civil Service Reform Act Claim Construction Clapper v. Amnesty International Class Members Classen Immunotherapies Clear Error Standard Clinical Laboratory Testing Cloud Computing Code of Conduct Colleges Commonality Compelled Speech Competition Complaint Procedures Computer-Related Inventions Congressional Committees Congressional Investigations & Hearings Consent Consolidated Appropriations Act Consultants Contraceptive Coverage Mandate Controlled Substances Act Cookies Corporate Fines Corporate Governance Corporate Integrity Agreement Coupons CRA Credibility Credit Monitoring Creditors Customer-Loyalty Programs CVS Cybersecurity Framework Data Collection Data Processors Data Theft Daubert Ruling Daubert Standards Davis-Bacon Act De Novo Standard of Review DEA Declaratory Judgments Declaratory Rulings Defamation Denial of Insurance Coverage Department of Health and Human Services Department of Insurance Department of Revenue Design Defects Destruction of Evidence Diagnostic Tests Digital Health Directed Verdicts Disclosure Disgorgement Disparagement Distributors Diversity Diversity Jurisdiction Doctor-Patient Privilege Document Preservation Notices Domestic Violence Dormant Commerce Clause DQSA Draft Guidance Drug & Alcohol Abuse Dukes v Wal-Mart Duty to Deal E-Cigarettes E-Commerce EHealth Elan Pharmaceuticals Electronic Prescribing Eleventh Amendment Eli Lilly Employment Policies Enforcement ESRD Estoppel EU Exemptions Exxon Mobil Face-to-Face Narrative Requirement Facebook Failure to Report Failure To State A Claim Fair Market Value False Billing False Implied Certification Theory FBI FCPA FDA Warning Letters Federal Contractors FERA Fiduciary Duty Fines First-Filed Action Rule Foreign Nationals Forest Laboratories Former Employee Forum Non Conveniens Fourth Amendment France Fraud and Abuse Fraud in the Inducement Fraudulent Joinder Frivolous Lawsuits FTC Act FTC v Actavis GAO Genentech Genetic Testing Genuine Issue of Material Fact Government Claims Government Investigations Grey Market Halifax Hospital Halliburton Health Information Technologies Hearsay HEAT HIPAA Omnibus Rule Home Health Care Hospice Hospira Hospital Mergers Human Genome Project Humana IBM ICD-10 Indemnity Insurance Inducement Inducements Inequitable Conduct Inevitable Disclosure Doctrine Infectious Diseases Innovation Insurance Fraud Interim Guidance Interstate Commerce Inventors Investigations Irreparable Harm Janssen Pharmaceuticals Joint Infringement Joint Venture Judgment Creditors Judicial Review Jury Awards Kaiser Permanente Kappos KBR (formerly Kellogg Brown & Root) Laboratories Lanham Act Licensing Rights Limelight Limelight v Akamai Litigation Fees & Costs Local Ordinance Long Term Care Facilities Material Nonpublic Information Media Medical Research Medicare Advantage Medicare Fraud Strike Force MedPAC MedQuest Meningitis Mensing MIPS Misappropriation Misleading Statements Mobile Device Management Monopolization Mootness Motion to Amend MRI Multidistrict Litigation Mylan Pharmaceuticals Myriad v Ambry Negligent Infliction of Emotional Distress New Guidance New Legislation New Regulations Nexium NIST No-AG Agreement Non-Disclosure Agreement Notification Requirements NRDC Obviousness OMHA Open Enrollment Otsuka Pharmaceutical OxyContin Passwords Patent Examinations Patent Ownership Patent Trial and Appeal Board Patent-in-Suit Penalties Pensions Permanent Injunctions Petition For Rehearing Pfizer PHSA Physician Medicare Reimbursements Physician-Owned Distributors Planned Parenthood Pleadings PLIVA v Mensing Policy Exclusions Precision Medicine Initiative (PMI) Predominance Requirement Premera Blue Cross Prescribing Authority Pretext Price Discrimination Primary Jurisdiction Doctrine Prior Art Prior Express Consent Prior User Privacy Concerns Private Right of Action Privilege Waivers Probable Cause Product Defects Professional Conferences Property Owners Property Tax Proposed Legislation Proposed Regulation Public Comment Public Entities Public Health Insurance Marketplace Public Health Service Act Public Nuisance Public Offerings Public Use Purchase Price Qualified Health Plans Reasonable Expectation of Privacy Rebuttable Presumptions Registration Statement Reimbursements Religious Freedom Remand Respondeat Superior Restraint of Trade Revocation Ripeness Risk Management Risk Mitigation Robinson-Patman Act Rule Rule 26 Rules of Civil Procedure Safe Drug Disposal Safeway Inc Sales Tax SAMHSA Scienter Scientific Research Sealed Records Search Warrant Section 10(b) Section 10(b)-5 Securities Securities Exchange Act Securities Fraud Security Breach Security Risk Assessments Security Rule Self-Authentication Senate Finance Committee Sequenom Service Contract Act Sexual Harassment Shire Development v Watson Social Media Social Security Numbers Spouses Standard of Review Stare Decisis State Law Tort Claims Statement of Facts Statistical Sampling Statutory Damages Stipulations Stocks Strict Liability Stryker Ortho Sunshine Act Supervision Supplemental Evidence Supplemental Information Supplementary Protection Certificate Surveillance Takeda Pharmaceuticals Tax Fraud Tax Refunds Tax Returns Tax Tribunal Technology Technology-Assisted Review The Patent Act Theft Third-Party Third-Party Service Provider Threshold Requirements Tortious Interference Transvaginal Mesh UCLA UCLA Medical Center UK Unauthorized Access Unfair Competition Unfair Trade Practices Act Universal Health Services Inc v United States ex rel Escobar Universities Vacated Vital Pharmaceuticals Wage and Hour Waivers Walgreens Warning Letters Warrantless Searches Web Tracking Weight-Loss Products Wells Fargo Whistleblower Awards Whole Woman's Health v Hellerstedt Withdrawal Work Product Privilege Written Consent Wrongful Termination WSLA Wyeth Young Lawyers